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Abstract Raf-1 is extensively phosphorylated on Ser in both 
quiescent and mitogen-stimulated cells. To identify the respon-
sible kinase(s), cytosolic fractions of NIH 3T3 cells were 
analyzed for Ser621 peptide kinase activity. One major peak of 
activity was detected and identified as AMP-activated protein 
kinase (AMPK) by immunodepletion experiments. AMPK 
phosphorylated the catalytic domain of Raf-1, expressed in 
Escherichia coli as a soluble GST fusion protein, to generate a 
single tryptic |32P]phosphopeptide containing exclusively phos-
pho-Ser 2 . AMPK also phosphorylated full-length, kinase-
defective Raf-1 (K375M) to generate two [32P]phosphopeptides, 
one co-migrating with synthetic tryptic peptide containing 
phospho-Ser621 and the other with phospho-Ser 59. 
© Federation of European Biochemical Societies. 
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1. Introduction 
The Raf-1 serine/threonine protein kinase is a key effector 
for Ras, relaying signals from receptors to the nucleus via 
stimulation of M E K and the M A P kinases p44 m a P k /ERKl 
and p42m aPk /ERK2 [1]. Ras -GTP binds the NH 2 - terminal do-
main of Raf-1 and recruits Raf-1 to the plasma membrane [1] 
where Raf-1 is activated by processes that are still the subject 
of intense investigation. 
Phosphorylation of Raf-1 is important for its regulation [2]. 
Activation of Raf-1 in vitro by membranes from v-Ras and v-
Src transformed cells requires A T P [3]. Raf-1 is phosphory-
lated at Y3 4 0 , and possibly also at Y3 4 1 , and enzymatically 
activated in Sf9 cells and N I H 3T3 cells expressing Ras 
and mutationally activated Src (SrcYo2TF), whereas doubly mu-
tated Raf-1 (F340<341) is not [2,4]. In addition to Y340*341, sev-
eral serine/threonine residues have been studied as sites of 
potential regulatory phosphorylation [2]. The studies de-
scribed herein concern Ser621 near the COOH-terminus. 
Mutat ional and biochemical studies of Raf-1 indicate an 
important role of phosphorylated Ser621 in Raf-1 structure 
and regulation (see Section 4). Ser621 was identified as an in 
vivo site of Raf-1 phosphorylation in Sfì cells and N I H 3T3 
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cells [5]. Ser621 is likely to be phosphorylated by kinase(s) 
other than Raf-1 since phosphopeptide maps of kinase-defec-
tive Raf-1 (K375M) contain [32P]Ser621 phosphopeptide. How-
ever, treatment of N I H 3T3 cells with platelet-derived growth 
factor, a potent Raf activator, did not detectably alter abun-
dance of Ser621 [32P]phosphopeptide under the experimental 
methods used [5]. In this paper, we identify the principal 
Raf-1 Ser621 kinase activity present in cytosolic extracts of 
N I H 3T3 cells as AMP-activated protein kinase (AMPK) . 
Identification of A M P K as a Ser621 kinase has important im-
plications for studies of Raf-1 regulation. 
2. Materials and methods 
2.1. Materials 
Synthetic Raf-1 Ser621 peptide SLPKINRSAS621EPSLHRi? (R, 
added) was used for peptide kinase assays, and peptide KINRSA-
SEPSLHR for peptide mapping after phosphorylation and tryptic 
cleavage. The Raf-1 259 peptide RQRSTS259TPNVHMVSTTLPVDS-
RMIE was similarly used. AMPK was purified from rat liver as far as 
the gel filtration step [6]. C-subunit of PKA was purified from bovine 
heart [7]. GST-22W Raf-1 [8] was expressed in E. coli and purified. 
FLAG-tagged K375M Raf-1 was expressed in Sfì cells and partially 
purified essentially as described [9], 
2.2. Cell culture and preparation of cell extracts 
NIH 3T3 cells (ATCC CRL-1658) were grown to confluency in 
DMEM supplemented with 5% calf serum (Gibco-BRL). Cells 
(6x150 mm plates) were starved overnight in serum-free DMEM. 
Plates were washed twice with cold PBS and placed on ice. Cells 
were scraped from the plate in 1 ml/plate lysis buffer (25 mM Tris-
HC1, pH 7.9, at 4°C, 0.5 mM EDTA, 0.5 mM EGTA, 0.3 M sucrose, 
1 mM DTT, 1 uM MCLR-LR, 200 uM Na2V04 , 5 mg/ml pepstatin, 
1 mg/ml aprotinin, 5 mg/ml E64, 1 mM Pefabloc-SC (Boehringer-
Mannheim)). Cells were homogenized in a Teflon/glass homogenizer 
and centrifuged at 3000 Xg. The supernatant was centrifuged at 
lOOOOOXgfor 20 min (SI00). 
2.3. Column chromatography 
SI00 (above) was diluted to 10 ml in buffer B (25 mM Tris-HCl, 
pH 7.9 at 4°C, 1 mM EDTA, 1 mM EGTA, 0.1% (v/v) NP-40, 10 
mM benzamidine) and applied to a MonoQ HR5/5 column (LKB-
Pharmacia). The column was developed at 0.5 ml/min with a NaCl 
gradient from 0 to 0.5 M over 50 ml, following collection of the flow-
through (fractions 1-10). One milliliter fractions were collected into 
tubes already containing glycerol and protease and phosphatase in-
hibitors for final concentrations of: 10% (w/v) glycerol, 1 ug/ml apro-
tinin, 1 ug/ml pepstatin, 1 mM Pefabloc-SC, 0.5 uM MCLR. 
2.4. Kinase assays 
Peptide kinase assays (25 ul, final volume) were performed in du-
plicate by mixing on ice 15 ml of the indicated fractions with 5 ml of 
the peptide stock (1 mg/ml) and 2.5 ul of 10X kinase assay buffer (0.2 
M Tris-HCl, 0.2 M ß-glycerol phosphate, 5 mM EGTA, 0.1 M 
MgCl2, 10 mM MnCl2 (pH 7.8 at 22°C)). Reactions (30°C, 20 min) 
were initiated by addition of 2.5 ul of [y-32P]ATP (final concentration, 
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50 uM (5 cpm/fmol)). Portions (15 ul) were transferred to P81 paper 
for determination of 32P incorporation. 
2.5. Immunodepletion of AMPK from MonoQ fractions 
Immunoprecipitations were performed in duplicate with 300 ul of 
indicated fractions, 20 |xl of protein A agarose (Pierce) and 1 |xl of 
pre-immune serum or antiserum to the C-terminal 217 residues of the 
AMPKß subunit [10]. Binding was carried out for 2 h at 4°C. Beads 
(washed twice with 1 X kinase assay buffer) and the initial supernatant 
were separately assayed. 
2.6. Phosphopeptide mapping and Edman degradation of GST-22W 
Bacterially expressed GST-22W Raf-1 (aa 306-648) [8] was partially 
purified (fusion protein ~20% of total) and 32P-phosphorylated to 
~0.2 mol/mol by rat liver AMPK. [32P]GST-22W (63 kDa) was ex-
cised from the gel after SDS-PAGE and digested with trypsin. The 
digest was analyzed by HPLC [11]. Radioactive peaks were subjected 
to Edman sequencing to determine the cycle of 32P release [12]. 
2.7. Phosphopeptide mapping of K375M Raf-1 
Partially purified K375M Raf-1 was treated sequentially with FSBA 
[13], and catalytic subunit of PP2A prior to use. PP2A-treated K375M 
Raf-1 (1.5 ug) was 32P-labeled with AMPK, resolved by SDS-PAGE 
(10% gel), and transferred to an Immobilon-CD membrane (Milli-
pore). The [32P]K375M Raf-1 band was excised, and the protein 
was digested on the matrix with sequencing grade modified-trypsin 
(Promega) according to the manufacturer's instructions. Membrane 
pieces were pre-treated and peptides were recovered as described 
[14]. Recovery of 32P in the supernatant was £80%. The supernatant 
was lyophilized and portions subjected to 2-dimensional phosphopep-
tide mapping by HVE/TLC using pH 1.9 buffer, 30 min at 1 kV for 
HVE and n-butanol/pyridine/glacial acetic acid/water (75:50:15:60) 
for TLC. Ser621 and Ser259 peptides were 32P-labeled by AMPK 
(Ser621 peptide) or C-subunit of PKA (Ser259 peptide), purified by 
HPLC, digested with trypsin, and re-isolated by HPLC before use. 
3. Results 
3.1. NIH 3T3 cells contain a Sere21 peptide kinase 
Studies of protein serine kinases have demonstrated that 
specificity for substrate recognition is dependent on the pri-
mary amino acid sequence in which the serine acceptor re-
sides. The residues determining specificity usually reside any-
where from P—5 to P+5 (where P represents the 
phosphorylated serine) [15]. The synthetic peptide 
SLPKINRSAS621EPSLHRR was used to screen for Ser621 
kinases in extracts of NIH 3T3 cells. Two peaks of Ser621 
peptide kinase activity were detected in fractions from 
MonoQ chromatography of cytosolic supernatants prepared 
from NIH 3T3 cells (Fig. 1). The major Ser621 peptide kinase 
activity eluted during the gradient at ~0 .2 M NaCl, while a 
minor peak eluted at ~0.1 M NaCl. No activity was detect-
able in fractions from the flow-through (Fig. 1). 
Ser621 resides in a sequence exactly matching the recogni-
tion motif of AMPK [16]. AMPK is a heterotrimeric aßy 
enzyme consisting of catalytic a-subunit and non-catalytic 
ß- and y-subunits [10,17,18]. AMPK is extremely sensitive to 
stresses which deplete ATP, and is readily activated during 
harvesting of cells unless appropriate methods are used [19-
21]. Studies of synthetic peptides and of AMPK sites in phys-
iologic substrates indicate a strong preference of AMPK for 
Ser/Thr with hydrophobic residues (M, V, L, I, or F) in the 
P—5 and P+4 positions and a single basic residue (R, K, H) at 
P - 4 or P - 3 [16]. Furthermore, AMPK elutes from MonoQ 
at ~0 .2 M NaCl [6,17], as did Ser621 kinase activity (Fig. 1). 
3.2. Immunodepletion with anti-AMPK$ antiserum 
Portions of MonoQ fractions were incubated with control 
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Fig. 1. Characterization of Ser621 peptide kinase activity by MonoQ 
chromatography. Cytosolic supernatants were prepared from 
NIH 3T3 cells, fractionated by MonoQ HR5/5 chromatography 
(pH 7.9 at 4°C), and fractions obtained were assayed for Ser621 pep-
tide kinase activity. 
sera or antisera to the rat AMPKß subunit [10], together with 
protein A-agarose beads, and tested for depletion of Ser621 
peptide kinase activity from the supernatants (Fig. 2). Immu-
noprecipitation with anti-AMPKß antiserum, but not with 
pre-immune serum, depleted the major peak of Ser621 peptide 
kinase activity (eluting at 0.2 M NaCl) from the supernatant. 
The activity was recovered in the pellet. Similarly, when anti-
AMPKß immunoprecipitates were analyzed by Western blot-
ting with the same antibody, a 38 kDa immunoreactive 
AMPKß band was found only in the fractions corresponding 
to the major peak (data not shown). These experiments iden-
tify the major peak of Ser621 kinase activity as AMPK. The 
minor peak of Ser621 peptide kinase activity (eluting at ~0.1 
M NaCl) was not depleted by anti-AMPKß serum and was 
inhibited by Walsh PKI peptide [22] (Fig. 2), demonstrating 
that it corresponded to the C-subunit of PKA. 
3.3. AMPKphosphorylates GST-22W Raf-1 exclusively on 
Ser621 
AMPK phosphorylated bacterial GST-22W Raf-1 to a stoi-
chiometry of ~0 .2 mol/mol exclusively on serine (data not 
shown). All of the 32P incorporated appeared in a single 
[32P]phosphopeptide after tryptic digestion and HPLC (Fig. 
3A). This phosphopeptide co-migrated with a synthetic Raf-
1 tryptic [32P]phosphopeptide (SAS621EPSLHR), generated by 
digestion of an NH2-terminally extended peptide that had 
been phosphorylated in vitro by AMPK (Fig. 3A). The 
Kmax of phosphorylation of the Ser
621 peptide was 90% of 
that using the SAMS peptide, while the Km was somewhat 
higher (100 vs. 30 uM) (data not shown). Release of 32P 
from the Raf-1 22W phosphopeptide occurred in cycle 3 dur-
ing Edman degradation (Fig. 3B), as did release from syn-
thetic peptide (data not shown). These results prove that 
AMPK phosphorylates GST-22W Raf-1 in vitro exclusively 
on Ser621. 
3.4. Phosphopeptide mapping of K375M Raf-1 
To determine whether AMPK also phosphorylates a more 
native Raf-1 protein on Ser621, we partially purified kinase-
defective K375M Raf-1 from Sf9 cells. Prior to phosphoryla-
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Fig. 2. Immunodepletion of peptide kinase activity from MonoQ 
fractions. NIH 3T3 cytosols were fractionated over MonoQ as in 
Fig. 1. Top panel: Selected fractions were mixed with protein A 
and anti-ß-AMPK or pre-immune (PI) serum and the pellet or 
supernatant (sup) assayed for Ser621 peptide kinase activity. Bottom 
panel: Walsh inhibitor (PKI, 10 uM final) was added to the pre-im-
mune supernatant prior to p81 assay. 
tion, the K375M preparation was treated with FSBA to in-
activate endogenous kinases, and then treated with PP2A to 
increase availability of phospho-acceptor sites. In the absence 
of exogenous kinase, there was no detectable phosphorylation 
of K375M Raf (data not shown). A M P K generated two tryp-
tic [32P]phosphopeptides in K375M Fig. 4. These phospho-
peptides co-migrated with synthetic marker peptides for 
Ser621 and Ser259. Thus, Ser621 in insect cell K375M is also 
an in vitro substrate for A M P K . Ser259 has hydrophobic res-
idue at P+4 and the required basic residue at P—3, but lacks 
hydrophobic residue in the P—5 position [5]. On this basis, 
Ser259 would be predicted to be less favorable as an A M P K 
site than Ser621. The preparation of A M P K was tested for 
contaminating P K A by incubation of the kinase with the 
P K A substrate peptide, Kemptide [23]. Under standard assay 
conditions, there was no detectable phosphorylation of Kemp-
tide (30 u M final). Similarly, the phosphorylation of SAMS 
peptide was unaffected by the inclusion of 10 u M P K I (data 
not shown). 
4. Discussion 
We identified A M P K as the major Ser621 kinase in cytosolic 
supernatants from N I H 3T3 cells. We strongly suspect that 
A M P K is a Ser621 kinase in vivo. Ser621 is known to be highly 
phosphorylated in Raf-1 isolated from insect and mammalian 
cells. The sequence surrounding Ser621 conforms to the 
A M P K consensus, and the Km and F m a x obtained for the 
Ser621 peptide in vitro are comparable to those for the 
SAMS peptide, which derives from a known physiologic 
A M P K phosphorylation site in acetyl-CoA carboxylase. 
A M P K exclusively phosphorylates Ser621 in Raf-1 22W, and 
phosphorylates Ser621 and Ser259 in full-length Raf-1. The 
major peak of Ser621 peptide kinase activity detectable in ly-
sates from N I H 3T3 cells is unequivocally A M P K . 
The role of phosphorylated Ser621 in Raf-1 is unclear. Raf-1 
Ser621 Ala mutants of Raf-1 expressed in Sf9 or human T cells 
are inactive under basal conditions, and cannot be stimulated 
by co-expression with Ras and SrcY 5 2 7 F [5] or treatment with 
phorbol esters [10]. These data suggest that phosphorylation 
of Ser621 is required for activity, however, effects of Ser621 Ala 
mutat ion on folding or thermal lability cannot be excluded. 
Recently, Mischak et al. [24] reported that incubation of GST-
GNXRaf-1 (lacking the NH 2 - terminal regulatory domain) 
with A T P / M g resulted in loss of activity, concomitant with 
phosphorylation of Ser621. The kinase responsible for this 
phosphorylation is likely to be a contaminating or co-purify-
ing activity. The catalytic subunit of P K A also phosphory-
lated Ser621 in vitro, while its overexpression in intact cells 
resulted in increased phosphorylation of Ser621 and decreased 
activity of Raf-1. These results suggest that phosphorylation 
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Fig. 3. Tryptic phosphopeptide analysis by HPLC and Edman deg-
radation of AMPK-phosphorylated bacterial GST 22W Raf-1. A: 
HPLC analysis of in vitro phosphorylated, trypsinized GST 22W 
Raf or synthetic peptide. B: Edman degradation of tryptic peptide 
SASEPSLHR with counts released exclusively at the third position, 
corresponding to Ser621. Data obtained for the synthetic peptide 
was identical (not shown). 
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rylated in rat liver under basal conditions [21,29], and though 
there is 80% inactivation of HMG-CoA reductase under se-
vere stress conditions, [20] phosphorylation increases only 2.5-
fold. The phosphorylation of key substrates for AMPK may 
be poised at this high basal level so that even a mild stress 
produces a large effect on activity, and thus the 'constitutive' 
nature of the Ser621 phosphorylation of Raf-1 may paradoxi-
cally indicate its importance in the regulation of Raf activity. 
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